Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer

The aim of this trial was to investigate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of heavily pretreated recurrent or persistent epithelial ovarian cancer (EOC). Patients with recurrent or persistent EOC who had measurable disease and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Heeseok, Kim, Tae-Joong, Choi, Chel Hun, Lee, Jeong-Won, Lee, Je-Ho, Bae, Duk-Soo, Kim, Byoung-Gie
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752782/
https://www.ncbi.nlm.nih.gov/pubmed/19794997
http://dx.doi.org/10.3346/jkms.2009.24.5.945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752782/
https://www.ncbi.nlm.nih.gov/pubmed/19794997
http://dx.doi.org/10.3346/jkms.2009.24.5.945

Ejemplares similares